Outcomes of Wilms tumor treatment in western Kenya
- PMID: 34908225
- DOI: 10.1002/pbc.29503
Outcomes of Wilms tumor treatment in western Kenya
Abstract
Background/objectives: Wilms tumor (WT) is a curable type of cancer with 5-year survival rates of over 90% in high-income countries, whereas this is less than 50% in low- and middle-income countries. We assessed treatment outcomes of children with WT treated at a large Kenyan teaching and referral hospital.
Design/methods: We conducted a retrospective record review of children diagnosed with WT between 2013 and 2016. Treatment protocol consisted of 6 weeks of preoperative chemotherapy and surgery, and 4-18 weeks of postoperative chemotherapy depending on disease stage. Probability of event-free survival (pEFS) and overall survival (pOS) was assessed using Kaplan-Meier method with Cox regression analysis. Competing events were analyzed with cumulative incidences and Fine-Gray regression analysis.
Results: Of the 92 diagnosed patients, 69% presented with high-stage disease. Two-year observed EFS and OS were, respectively, 43.5% and 67%. Twenty-seven percent of children died, 19% abandoned treatment, and 11% suffered from progressive or relapsed disease. Patients who were diagnosed in 2015-2016 compared to 2013-2014 showed higher pEFS. They less often had progressive or relapsed disease (p = .015) and borderline significant less often abandonment of treatment (p = .09). Twenty-nine children received radiotherapy, and 2-year pEFS in this group was 86%.
Conclusion: Outcome of children with WT improved over the years despite advanced stage at presentation. Survival probabilities of patients receiving comprehensive therapy including radiation are approaching those of patients in high-income countries. Additional improvement could be achieved by ensuring that patients receive all required treatment and working on earlier diagnosis strategies.
Keywords: Wilms tumor; chemotherapy; outcomes research; pediatric oncology; sub-Saharan Africa; surgery.
© 2021 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
References
REFERENCES
-
- Szychot E, Apps J, Pritchard-Jones K. Wilms' tumor: biology, diagnosis and treatment. Transl Pediatr. 2014;3(1):12-24.
-
- Cunningham ME, Klug TD, Nuchtern JG, et al. Global disparities in Wilms tumor. J Surg Res. 2020;247:34-51.
-
- Hadley LG, Rouma BS, Saad-Eldin Y. Challenge of pediatric oncology in Africa. Semin Pediatr Surg. 2012;21(2):136-141.
-
- Global initiative for childhood cancer. World Health Organization. Accessed April 20, 2021. https://www.who.int/cancer/childhood-cancer/en/
-
- WHO global initiative for childhood cancer. St. Jude Children's Research Hospital. Accessed June 2, 2021. https://www.stjude.org/global/collaborating-to-cure/global-initiative.html